Compared side by side

Ipamorelin vs GHRP-2: how they differ

Reviewed How we check the libraryPublished by PepVault

The short answer

Both release growth hormone through the ghrelin receptor, and the difference is selectivity: ipamorelin released GH without raising cortisol or ACTH in animal studies, while GHRP-2 is more potent but less selective, so along with GH and IGF-1 it also raises cortisol and prolactin. Both are taken 2–3 times a day. GHRP-2 is approved in Japan only as a diagnostic test for GH deficiency, and ipamorelin was never approved.

Side by side

ComparedIpamorelinGHRP-2
CategoryGrowth hormoneGrowth hormone
Also known asIPAMGrowth Hormone Releasing Peptide-2, Pralmorelin
What it isConsidered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides.A potent growth hormone secretagogue: more potent than Ipamorelin but less selective, so along with GH and IGF-1 it also raises cortisol and prolactin.
How it worksSelective growth hormone secretagogue and ghrelin receptor agonist. In animal studies it released GH without raising cortisol or ACTH, and users report milder hunger than with GHRP-6. Considered one of the cleanest GH pulses available.Potent GH secretagogue that strongly stimulates GH release via ghrelin receptor agonism. More potent than GHRP-6 in animal tests, and users commonly report less appetite stimulation. Also stimulates IGF-1 production.
Commonly reportedDeeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6. Its human data are a small GH study and phase 2 trials in surgical patients; it was never approved.Noticeable hunger after a dose (milder than GHRP-6), a flush or head rush after injecting, and water retention or tingling hands with ongoing use. Approved in Japan only as a diagnostic test for GH deficiency.
Studied rangeResearch range: 200–300 mcg, starting dose 200 mcg. Studied in research — not a recommendation.Research range: 100–300 mcg. Studied in research — not a recommendation.
How often2–3x daily, best fasted or before bed2–3x daily
Half-life~2 hours (measured in healthy men, given IV)~30 min
RouteSubQ injection, IM injectionSubQ injection
Typical runCommonly 8–12 weeks on, 4 weeks off to avoid receptor desensitisation. Some run longer with breaks.8–12 weeks. Desensitisation is less rapid than with GHRP-6 or Hexarelin (no head-to-head data), but cycles are still recommended.
EvidenceModerate: animal studies + some human dataModerate: animal studies + some human data
Common side effectsHeadache, flushing, nausea, water retention, numbness/tinglingIncreased appetite, water retention, fatigue, headache, cortisol/prolactin increase

Typical run: Community practice — opinions vary. Not a clinical recommendation.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Taking ipamorelin or GHRP-2? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

Ipamorelin

  • Day 1–14 Sleep is deepening
  • Day 14–28 Recovery is noticeably faster
  • Day 28–56 Body composition shifts showing up
  • Day 56–84 Cycle-end + planned break

Every card for ipamorelin, with its sources

GHRP-2

  • Day 1–14 Hits harder than Ipamorelin
  • Day 14–56 Recovery and growth are accelerating

Every card for GHRP-2, with its sources

Questions people ask

How long do ipamorelin and GHRP-2 last?

The half-life of ipamorelin is ~2 hours (measured in healthy men, given IV). The half-life of GHRP-2 is ~30 min.

How often are ipamorelin and GHRP-2 taken?

Ipamorelin: 2–3x daily, best fasted or before bed. Routes: SubQ injection, IM injection. GHRP-2: 2–3x daily. Route: SubQ injection.

How are ipamorelin and GHRP-2 dosed in research?

The research range for ipamorelin is 200–300 mcg, with a 200 mcg starting dose. The research range for GHRP-2 is 100–300 mcg. Studied in research — not a recommendation.

What are the common side effects of ipamorelin and GHRP-2?

For ipamorelin, the library lists: headache, flushing, nausea, water retention, numbness/tingling. For GHRP-2: increased appetite, water retention, fatigue, headache, cortisol/prolactin increase.

Each one in full

Track it in the app

PepVault for iPhone

Taking ipamorelin or GHRP-2? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo